Dapagliflozin ameliorates diabetic kidney disease by inhibiting oxidative stress and AIM2-dependent pyroptosis via SIRT1 activation

Biochemical Pharmacology 2026

View at publisher

Authors: H Y Wang, Chunliu Li, X J Wang, Feng Yan, Bihan Li, Jiahui Gao, Kuo Zhang, Jiahong Wang

DOI: 10.1016/j.bcp.2026.118200

Cited by: 1

References: 50

Fields of Study & Subjects

Inflammasome and immune disorders Dialysis and Renal Disease Management Adenosine and Purinergic Signaling

References 50